EE538 Impact of Nirsevimab on the Health Burden and Costs of Respiratory Syncytial Virus (RSV) in the Infant Population From the Healthcare System in Argentina
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.920
https://www.valueinhealthjournal.com/article/S1098-3015(25)03477-1/fulltext
Title :
EE538 Impact of Nirsevimab on the Health Burden and Costs of Respiratory Syncytial Virus (RSV) in the Infant Population From the Healthcare System in Argentina
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03477-1&doi=10.1016/j.jval.2025.09.920
First page :
Section Title :
Open access? :
No
Section Order :
10477